- call +1-201-465-4211
- email sales@marketresearchplace.com
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities.
Market Analysis and Insights: Global Sacral Neuromodulation System Market
In 2019, the global Sacral Neuromodulation System market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Sacral Neuromodulation System Scope and Market Size
Sacral Neuromodulation System market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sacral Neuromodulation System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Sacral Neuromodulation System market is segmented into Internal Neuromodulation System, External Neuromodulation System, etc.
Segment by Application, the Sacral Neuromodulation System market is segmented into Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, etc.
Regional and Country-level Analysis
The Sacral Neuromodulation System market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sacral Neuromodulation System market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape and Sacral Neuromodulation System Market Share Analysis
Sacral Neuromodulation System market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Sacral Neuromodulation System business, the date to enter into the Sacral Neuromodulation System market, Sacral Neuromodulation System product introduction, recent developments, etc.
The major vendors include Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US), Cyberonics, Inc. (US), BioControl Medical (Israel), etc.
This report focuses on the global Sacral Neuromodulation System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sacral Neuromodulation System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)
Market segment by Type, the product can be split into
Internal Neuromodulation System
External Neuromodulation System
Market segment by Application, split into
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Sacral Neuromodulation System status, future forecast, growth opportunity, key market and key players.
To present the Sacral Neuromodulation System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Sacral Neuromodulation System are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sacral Neuromodulation System Revenue
1.4 Market Analysis by Type
1.4.1 Global Sacral Neuromodulation System Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Internal Neuromodulation System
1.4.3 External Neuromodulation System
1.5 Market by Application
1.5.1 Global Sacral Neuromodulation System Market Share by Application: 2020 VS 2026
1.5.2 Spinal Cord Stimulation
1.5.3 Deep Brain Stimulation
1.5.4 Sacral Nerve Stimulation
1.5.5 Vagus Nerve Stimulation
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Sacral Neuromodulation System Market Perspective (2015-2026)
2.2 Sacral Neuromodulation System Growth Trends by Regions
2.2.1 Sacral Neuromodulation System Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sacral Neuromodulation System Historic Market Share by Regions (2015-2020)
2.2.3 Sacral Neuromodulation System Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sacral Neuromodulation System Market Growth Strategy
2.3.6 Primary Interviews with Key Sacral Neuromodulation System Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sacral Neuromodulation System Players by Market Size
3.1.1 Global Top Sacral Neuromodulation System Players by Revenue (2015-2020)
3.1.2 Global Sacral Neuromodulation System Revenue Market Share by Players (2015-2020)
3.1.3 Global Sacral Neuromodulation System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sacral Neuromodulation System Market Concentration Ratio
3.2.1 Global Sacral Neuromodulation System Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sacral Neuromodulation System Revenue in 2019
3.3 Sacral Neuromodulation System Key Players Head office and Area Served
3.4 Key Players Sacral Neuromodulation System Product Solution and Service
3.5 Date of Enter into Sacral Neuromodulation System Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Sacral Neuromodulation System Historic Market Size by Type (2015-2020)
4.2 Global Sacral Neuromodulation System Forecasted Market Size by Type (2021-2026)
5 Sacral Neuromodulation System Breakdown Data by Application (2015-2026)
5.1 Global Sacral Neuromodulation System Market Size by Application (2015-2020)
5.2 Global Sacral Neuromodulation System Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sacral Neuromodulation System Market Size (2015-2020)
6.2 Sacral Neuromodulation System Key Players in North America (2019-2020)
6.3 North America Sacral Neuromodulation System Market Size by Type (2015-2020)
6.4 North America Sacral Neuromodulation System Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sacral Neuromodulation System Market Size (2015-2020)
7.2 Sacral Neuromodulation System Key Players in Europe (2019-2020)
7.3 Europe Sacral Neuromodulation System Market Size by Type (2015-2020)
7.4 Europe Sacral Neuromodulation System Market Size by Application (2015-2020)
8 China
8.1 China Sacral Neuromodulation System Market Size (2015-2020)
8.2 Sacral Neuromodulation System Key Players in China (2019-2020)
8.3 China Sacral Neuromodulation System Market Size by Type (2015-2020)
8.4 China Sacral Neuromodulation System Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sacral Neuromodulation System Market Size (2015-2020)
9.2 Sacral Neuromodulation System Key Players in Japan (2019-2020)
9.3 Japan Sacral Neuromodulation System Market Size by Type (2015-2020)
9.4 Japan Sacral Neuromodulation System Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sacral Neuromodulation System Market Size (2015-2020)
10.2 Sacral Neuromodulation System Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sacral Neuromodulation System Market Size by Type (2015-2020)
10.4 Southeast Asia Sacral Neuromodulation System Market Size by Application (2015-2020)
11 India
11.1 India Sacral Neuromodulation System Market Size (2015-2020)
11.2 Sacral Neuromodulation System Key Players in India (2019-2020)
11.3 India Sacral Neuromodulation System Market Size by Type (2015-2020)
11.4 India Sacral Neuromodulation System Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sacral Neuromodulation System Market Size (2015-2020)
12.2 Sacral Neuromodulation System Key Players in Central & South America (2019-2020)
12.3 Central & South America Sacral Neuromodulation System Market Size by Type (2015-2020)
12.4 Central & South America Sacral Neuromodulation System Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Medtronic, Inc. (US)
13.1.1 Medtronic, Inc. (US) Company Details
13.1.2 Medtronic, Inc. (US) Business Overview and Its Total Revenue
13.1.3 Medtronic, Inc. (US) Sacral Neuromodulation System Introduction
13.1.4 Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020))
13.1.5 Medtronic, Inc. (US) Recent Development
13.2 Boston Scientific Corporation (US)
13.2.1 Boston Scientific Corporation (US) Company Details
13.2.2 Boston Scientific Corporation (US) Business Overview and Its Total Revenue
13.2.3 Boston Scientific Corporation (US) Sacral Neuromodulation System Introduction
13.2.4 Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
13.2.5 Boston Scientific Corporation (US) Recent Development
13.3 St. Jude Medical, Inc. (US)
13.3.1 St. Jude Medical, Inc. (US) Company Details
13.3.2 St. Jude Medical, Inc. (US) Business Overview and Its Total Revenue
13.3.3 St. Jude Medical, Inc. (US) Sacral Neuromodulation System Introduction
13.3.4 St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
13.3.5 St. Jude Medical, Inc. (US) Recent Development
13.4 Synapse Biomedical, Inc. (US)
13.4.1 Synapse Biomedical, Inc. (US) Company Details
13.4.2 Synapse Biomedical, Inc. (US) Business Overview and Its Total Revenue
13.4.3 Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Introduction
13.4.4 Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
13.4.5 Synapse Biomedical, Inc. (US) Recent Development
13.5 Nevro Corporation (US)
13.5.1 Nevro Corporation (US) Company Details
13.5.2 Nevro Corporation (US) Business Overview and Its Total Revenue
13.5.3 Nevro Corporation (US) Sacral Neuromodulation System Introduction
13.5.4 Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
13.5.5 Nevro Corporation (US) Recent Development
13.6 Neurosigma, Inc. (US)
13.6.1 Neurosigma, Inc. (US) Company Details
13.6.2 Neurosigma, Inc. (US) Business Overview and Its Total Revenue
13.6.3 Neurosigma, Inc. (US) Sacral Neuromodulation System Introduction
13.6.4 Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
13.6.5 Neurosigma, Inc. (US) Recent Development
13.7 Neuropace, Inc. (US)
13.7.1 Neuropace, Inc. (US) Company Details
13.7.2 Neuropace, Inc. (US) Business Overview and Its Total Revenue
13.7.3 Neuropace, Inc. (US) Sacral Neuromodulation System Introduction
13.7.4 Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
13.7.5 Neuropace, Inc. (US) Recent Development
13.8 Neuronetics, Inc. (US)
13.8.1 Neuronetics, Inc. (US) Company Details
13.8.2 Neuronetics, Inc. (US) Business Overview and Its Total Revenue
13.8.3 Neuronetics, Inc. (US) Sacral Neuromodulation System Introduction
13.8.4 Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
13.8.5 Neuronetics, Inc. (US) Recent Development
13.9 Cyberonics, Inc. (US)
13.9.1 Cyberonics, Inc. (US) Company Details
13.9.2 Cyberonics, Inc. (US) Business Overview and Its Total Revenue
13.9.3 Cyberonics, Inc. (US) Sacral Neuromodulation System Introduction
13.9.4 Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020)
13.9.5 Cyberonics, Inc. (US) Recent Development
13.10 BioControl Medical (Israel)
13.10.1 BioControl Medical (Israel) Company Details
13.10.2 BioControl Medical (Israel) Business Overview and Its Total Revenue
13.10.3 BioControl Medical (Israel) Sacral Neuromodulation System Introduction
13.10.4 BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2015-2020)
13.10.5 BioControl Medical (Israel) Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Sacral Neuromodulation System Key Market Segments
Table 2. Key Players Covered: Ranking by Sacral Neuromodulation System Revenue
Table 3. Ranking of Global Top Sacral Neuromodulation System Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sacral Neuromodulation System Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Internal Neuromodulation System
Table 6. Key Players of External Neuromodulation System
Table 7. Global Sacral Neuromodulation System Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Sacral Neuromodulation System Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Sacral Neuromodulation System Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Sacral Neuromodulation System Market Share by Regions (2015-2020)
Table 11. Global Sacral Neuromodulation System Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Sacral Neuromodulation System Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Sacral Neuromodulation System Market Growth Strategy
Table 17. Main Points Interviewed from Key Sacral Neuromodulation System Players
Table 18. Global Sacral Neuromodulation System Revenue by Players (2015-2020) (Million US$)
Table 19. Global Sacral Neuromodulation System Market Share by Players (2015-2020)
Table 20. Global Top Sacral Neuromodulation System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sacral Neuromodulation System as of 2019)
Table 21. Global Sacral Neuromodulation System by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Sacral Neuromodulation System Product Solution and Service
Table 24. Date of Enter into Sacral Neuromodulation System Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 27. Global Sacral Neuromodulation System Market Size Share by Type (2015-2020)
Table 28. Global Sacral Neuromodulation System Revenue Market Share by Type (2021-2026)
Table 29. Global Sacral Neuromodulation System Market Size Share by Application (2015-2020)
Table 30. Global Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 31. Global Sacral Neuromodulation System Market Size Share by Application (2021-2026)
Table 32. North America Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 34. North America Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 35. North America Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 36. North America Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 37. North America Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 38. Europe Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 40. Europe Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 42. Europe Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 44. China Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 45. China Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 46. China Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 47. China Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 48. China Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 49. China Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 50. Japan Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 52. Japan Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 54. Japan Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 58. Southeast Asia Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 60. Southeast Asia Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 62. India Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 63. India Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 64. India Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 65. India Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 66. India Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 67. India Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Sacral Neuromodulation System Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Sacral Neuromodulation System Market Share (2019-2020)
Table 70. Central & South America Sacral Neuromodulation System Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Sacral Neuromodulation System Market Share by Type (2015-2020)
Table 72. Central & South America Sacral Neuromodulation System Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Sacral Neuromodulation System Market Share by Application (2015-2020)
Table 74. Medtronic, Inc. (US) Company Details
Table 75. Medtronic, Inc. (US) Business Overview
Table 76. Medtronic, Inc. (US) Product
Table 77. Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 78. Medtronic, Inc. (US) Recent Development
Table 79. Boston Scientific Corporation (US) Company Details
Table 80. Boston Scientific Corporation (US) Business Overview
Table 81. Boston Scientific Corporation (US) Product
Table 82. Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 83. Boston Scientific Corporation (US) Recent Development
Table 84. St. Jude Medical, Inc. (US) Company Details
Table 85. St. Jude Medical, Inc. (US) Business Overview
Table 86. St. Jude Medical, Inc. (US) Product
Table 87. St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 88. St. Jude Medical, Inc. (US) Recent Development
Table 89. Synapse Biomedical, Inc. (US) Company Details
Table 90. Synapse Biomedical, Inc. (US) Business Overview
Table 91. Synapse Biomedical, Inc. (US) Product
Table 92. Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 93. Synapse Biomedical, Inc. (US) Recent Development
Table 94. Nevro Corporation (US) Company Details
Table 95. Nevro Corporation (US) Business Overview
Table 96. Nevro Corporation (US) Product
Table 97. Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 98. Nevro Corporation (US) Recent Development
Table 99. Neurosigma, Inc. (US) Company Details
Table 100. Neurosigma, Inc. (US) Business Overview
Table 101. Neurosigma, Inc. (US) Product
Table 102. Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 103. Neurosigma, Inc. (US) Recent Development
Table 104. Neuropace, Inc. (US) Company Details
Table 105. Neuropace, Inc. (US) Business Overview
Table 106. Neuropace, Inc. (US) Product
Table 107. Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 108. Neuropace, Inc. (US) Recent Development
Table 109. Neuronetics, Inc. (US) Business Overview
Table 110. Neuronetics, Inc. (US) Product
Table 111. Neuronetics, Inc. (US) Company Details
Table 112. Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 113. Neuronetics, Inc. (US) Recent Development
Table 114. Cyberonics, Inc. (US) Company Details
Table 115. Cyberonics, Inc. (US) Business Overview
Table 116. Cyberonics, Inc. (US) Product
Table 117. Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 118. Cyberonics, Inc. (US) Recent Development
Table 119. BioControl Medical (Israel) Company Details
Table 120. BioControl Medical (Israel) Business Overview
Table 121. BioControl Medical (Israel) Product
Table 122. BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2015-2020) (Million US$)
Table 123. BioControl Medical (Israel) Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sacral Neuromodulation System Market Share by Type: 2020 VS 2026
Figure 2. Internal Neuromodulation System Features
Figure 3. External Neuromodulation System Features
Figure 4. Global Sacral Neuromodulation System Market Share by Application: 2020 VS 2026
Figure 5. Spinal Cord Stimulation Case Studies
Figure 6. Deep Brain Stimulation Case Studies
Figure 7. Sacral Nerve Stimulation Case Studies
Figure 8. Vagus Nerve Stimulation Case Studies
Figure 9. Sacral Neuromodulation System Report Years Considered
Figure 10. Global Sacral Neuromodulation System Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Sacral Neuromodulation System Market Share by Regions: 2020 VS 2026
Figure 12. Global Sacral Neuromodulation System Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Sacral Neuromodulation System Market Share by Players in 2019
Figure 15. Global Top Sacral Neuromodulation System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sacral Neuromodulation System as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Sacral Neuromodulation System Revenue in 2019
Figure 17. North America Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Sacral Neuromodulation System Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Medtronic, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Medtronic, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 26. Boston Scientific Corporation (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Boston Scientific Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 28. St. Jude Medical, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. St. Jude Medical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 30. Synapse Biomedical, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Synapse Biomedical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 32. Nevro Corporation (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Nevro Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 34. Neurosigma, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Neurosigma, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 36. Neuropace, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Neuropace, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 38. Neuronetics, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Neuronetics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 40. Cyberonics, Inc. (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Cyberonics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 42. BioControl Medical (Israel) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. BioControl Medical (Israel) Revenue Growth Rate in Sacral Neuromodulation System Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
